Is Humana Stock Underperforming the S&P 500?
HumanaHumana(US:HUM) Yahoo Finance·2026-03-09 14:02

Company Overview - Humana Inc. (HUM) is headquartered in Louisville, Kentucky, and provides medical and specialty insurance products with a market cap of $21.6 billion [1] - The company offers coordinated health care through health maintenance organizations, point-of-service plans, and administrative services products [1] Market Position - HUM is classified as a large-cap stock, underscoring its size, influence, and dominance within the healthcare plans industry [2] - The company leads the Medicare Advantage sector with a substantial customer base and competitive edge, driven by a focused strategy [2] - Humana has diversified into healthcare services, including primary care and pharmacy benefit management, capturing more value in the healthcare chain [2] Stock Performance - HUM has experienced a significant decline, slipping 43.2% from its 52-week high of $315.35, achieved on September 5, 2025 [3] - Over the past three months, HUM stock declined 30.5%, underperforming the S&P 500 Index's 1.9% decline during the same period [3] - Year-to-date, shares of HUM fell 30.1% and dipped 32.6% over the past 52 weeks, notably underperforming the S&P 500's YTD 1.5% losses and 17.5% returns over the last year [3] Technical Indicators - HUM has been trading below its 50-day and 200-day moving averages since late January, confirming a bearish trend [4] Financial Results - In Q4, HUM reported an adjusted loss of $3.96 per share, which beat Wall Street expectations of $4.01 per share [5] - The company's adjusted revenue was $32.6 billion, surpassing Wall Street forecasts of $31.9 billion [5] - HUM expects full-year adjusted EPS to be $9 [5] Competitive Landscape - The Cigna Group (CI) has taken the lead over HUM in the competitive healthcare plans arena, showing resilience with a 1.3% loss on a YTD basis [6] - Wall Street analysts maintain a consensus "Moderate Buy" rating for HUM, with a mean price target of $219.13, suggesting a potential upside of 22.3% from current price levels [6]

Is Humana Stock Underperforming the S&P 500? - Reportify